Mirum Pharmaceuticals (MIRM) Change in Acquisitions & Divestments (2019 - 2026)

Mirum Pharmaceuticals' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $33.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 94.41% year-over-year to $33.9 million; the TTM figure through Mar 2026 stood at $90.9 million (up 143.48% YoY), while the FY2025 annual figure was $74.4 million, up 274.11% from the prior year.
• Change in Acquisitions & Divestments was $33.9 million for Q1 2026 at Mirum Pharmaceuticals, up from $13.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $64.5 million in Q1 2023 to a low of $3.0 million in Q4 2023.
• Historically, Change in Acquisitions & Divestments has averaged $28.1 million across 5 years, with a median of $27.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments tumbled 88.89% in 2023, then soared 304.8% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $27.0 million in 2022, then sank by 88.89% to $3.0 million in 2023, then jumped by 304.8% to $12.1 million in 2024, then advanced by 7.94% to $13.1 million in 2025, then jumped by 158.56% to $33.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $33.9 million (Q1 2026), $13.1 million (Q4 2025), and $18.8 million (Q3 2025), per Business Quant data.